Cargando…
Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge
Lymphadenopathies can be part of the clinical spectrum of several primary immunodeficiencies, including diseases with immune dysregulation and autoinflammatory disorders, as the clinical expression of benign polyclonal lymphoproliferation, granulomatous disease or lymphoid malignancy. Lymphadenopath...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374228/ https://www.ncbi.nlm.nih.gov/pubmed/34008169 http://dx.doi.org/10.1111/cei.13620 |
_version_ | 1783740070524616704 |
---|---|
author | Costagliola, Giorgio Consolini, Rita |
author_facet | Costagliola, Giorgio Consolini, Rita |
author_sort | Costagliola, Giorgio |
collection | PubMed |
description | Lymphadenopathies can be part of the clinical spectrum of several primary immunodeficiencies, including diseases with immune dysregulation and autoinflammatory disorders, as the clinical expression of benign polyclonal lymphoproliferation, granulomatous disease or lymphoid malignancy. Lymphadenopathy poses a significant diagnostic dilemma when it represents the first sign of a disorder of the immune system, leading to a consequently delayed diagnosis. Additionally, the finding of lymphadenopathy in a patient with diagnosed immunodeficiency raises the question of the differential diagnosis between benign lymphoproliferation and malignancies. Lymphadenopathies are evidenced in 15–20% of the patients with common variable immunodeficiency, while in other antibody deficiencies the prevalence is lower. They are also evidenced in different combined immunodeficiency disorders, including Omenn syndrome, which presents in the first months of life. Interestingly, in the activated phosphoinositide 3‐kinase delta syndrome, autoimmune lymphoproliferative syndrome, Epstein–Barr virus (EBV)‐related lymphoproliferative disorders and regulatory T cell disorders, lymphadenopathy is one of the leading signs of the entire clinical picture. Among autoinflammatory diseases, the highest prevalence of lymphadenopathies is observed in patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) and hyper‐immunoglobulin (Ig)D syndrome. The mechanisms underlying lymphoproliferation in the different disorders of the immune system are multiple and not completely elucidated. The advances in genetic techniques provide the opportunity of identifying new monogenic disorders, allowing genotype–phenotype correlations to be made and to provide adequate follow‐up and treatment in the single diseases. In this work, we provide an overview of the most relevant immune disorders associated with lymphadenopathy, focusing on their diagnostic and prognostic implications. |
format | Online Article Text |
id | pubmed-8374228 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83742282021-08-24 Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge Costagliola, Giorgio Consolini, Rita Clin Exp Immunol Review Lymphadenopathies can be part of the clinical spectrum of several primary immunodeficiencies, including diseases with immune dysregulation and autoinflammatory disorders, as the clinical expression of benign polyclonal lymphoproliferation, granulomatous disease or lymphoid malignancy. Lymphadenopathy poses a significant diagnostic dilemma when it represents the first sign of a disorder of the immune system, leading to a consequently delayed diagnosis. Additionally, the finding of lymphadenopathy in a patient with diagnosed immunodeficiency raises the question of the differential diagnosis between benign lymphoproliferation and malignancies. Lymphadenopathies are evidenced in 15–20% of the patients with common variable immunodeficiency, while in other antibody deficiencies the prevalence is lower. They are also evidenced in different combined immunodeficiency disorders, including Omenn syndrome, which presents in the first months of life. Interestingly, in the activated phosphoinositide 3‐kinase delta syndrome, autoimmune lymphoproliferative syndrome, Epstein–Barr virus (EBV)‐related lymphoproliferative disorders and regulatory T cell disorders, lymphadenopathy is one of the leading signs of the entire clinical picture. Among autoinflammatory diseases, the highest prevalence of lymphadenopathies is observed in patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) and hyper‐immunoglobulin (Ig)D syndrome. The mechanisms underlying lymphoproliferation in the different disorders of the immune system are multiple and not completely elucidated. The advances in genetic techniques provide the opportunity of identifying new monogenic disorders, allowing genotype–phenotype correlations to be made and to provide adequate follow‐up and treatment in the single diseases. In this work, we provide an overview of the most relevant immune disorders associated with lymphadenopathy, focusing on their diagnostic and prognostic implications. John Wiley and Sons Inc. 2021-06-20 2021-09 /pmc/articles/PMC8374228/ /pubmed/34008169 http://dx.doi.org/10.1111/cei.13620 Text en © 2021 The Authors. Clinical & Experimental Immunology published by John Wiley & Sons Ltd on behalf of British Society for Immunology https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Review Costagliola, Giorgio Consolini, Rita Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge |
title | Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge |
title_full | Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge |
title_fullStr | Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge |
title_full_unstemmed | Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge |
title_short | Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge |
title_sort | lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: an intriguing challenge |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374228/ https://www.ncbi.nlm.nih.gov/pubmed/34008169 http://dx.doi.org/10.1111/cei.13620 |
work_keys_str_mv | AT costagliolagiorgio lymphadenopathyatthecrossroadbetweenimmunodeficiencyandautoinflammationanintriguingchallenge AT consolinirita lymphadenopathyatthecrossroadbetweenimmunodeficiencyandautoinflammationanintriguingchallenge |